Evidence map›Paper›PMID 42256551›Full record

ArticleHemaSphere2026

Persistent

Jean-Edouard Martin, Julien Cliquot, Rathana Kim, Stéphanie Mathis, Jean-Michel Cayuela, Marie Passet, Baptiste Gaillard, Chantal Himberlin, André Baruchel, Raphaël Itzykson and 5 more

Abstract readLetter
In one paragraph

Article in HemaSphere, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Jean-Edouard MartinService d'Hématologie, AP-HP, hôpital Saint-Louis Université Paris Cité Paris France.
Julien CliquotLaboratoire d'Hématologie, CHU de Reims Université de Reims Champagne-Ardenne Reims France.
Rathana KimThe Leukemia Institute Paris Saint-Louis Paris France.ORCID https://orcid.org/0000-0002-9987-7237
Stéphanie MathisThe Leukemia Institute Paris Saint-Louis Paris France.
Jean-Michel CayuelaThe Leukemia Institute Paris Saint-Louis Paris France.ORCID https://orcid.org/0000-0002-6039-4270
Marie PassetThe Leukemia Institute Paris Saint-Louis Paris France.
Baptiste GaillardLaboratoire d'Hématologie, CHU de Reims Université de Reims Champagne-Ardenne Reims France.
Chantal HimberlinService d'Hématologie CHU de Reims Reims France.
André BaruchelThe Leukemia Institute Paris Saint-Louis Paris France.
Raphaël ItzyksonService d'Hématologie, AP-HP, hôpital Saint-Louis Université Paris Cité Paris France.
Jean SoulierThe Leukemia Institute Paris Saint-Louis Paris France.
Nicolas BoisselService d'Hématologie, AP-HP, hôpital Saint-Louis Université Paris Cité Paris France.
Emmanuel RaffouxService d'Hématologie, AP-HP, hôpital Saint-Louis Université Paris Cité Paris France.
Pascale Cornillet-LefebvreLaboratoire d'Hématologie, CHU de Reims Université de Reims Champagne-Ardenne Reims France.
Emmanuelle ClappierThe Leukemia Institute Paris Saint-Louis Paris France.ORCID https://orcid.org/0000-0001-7098-092X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42256551
PMCPMC13240339

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.